SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-22-034677
Filing Date
2022-06-24
Accepted
2022-06-23 19:52:35
Documents
13
Period of Report
2022-06-23
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K ea162013-8ka1_inmedphar.htm   iXBRL 8-K/A 29685
  Complete submission text file 0001213900-22-034677.txt   244682

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE inm-20220623.xsd EX-101.SCH 3202
3 XBRL DEFINITION FILE inm-20220623_def.xml EX-101.DEF 26195
4 XBRL LABEL FILE inm-20220623_lab.xml EX-101.LAB 35952
5 XBRL PRESENTATION FILE inm-20220623_pre.xml EX-101.PRE 24853
7 EXTRACTED XBRL INSTANCE DOCUMENT ea162013-8ka1_inmedphar_htm.xml XML 4692
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K/A | Act: 34 | File No.: 001-39685 | Film No.: 221036702
SIC: 2834 Pharmaceutical Preparations